FIP works closely with the press to support accurate, timely and impactful reporting on pharmacy practice, pharmacy education and pharmaceutical science and global health developments. FIP provides journalists and media professionals with access to policy developments, research, publications, campaigns and initiatives shaping health care worldwide.
FIP also supports media engagement through dedicated press registration and press benefits during the annual FIP world congress, offering accredited journalists opportunities to access scientific sessions, interviews with global pharmacy leaders and key developments from across the profession.
If you would like to join our press list to receive press releases, please email press@fip.org with your name, publication, job title and email address.
The Hague • 18 February 2021
A toolkit for medicines reconciliation, released today, is the latest resource produced by the International Pharmaceutical Federation (FIP) to support pharmacists in improving patient safety and contribute to the World Health Organization’s (WHO’s) third Global Patient Safety Challenge — “Medication without harm”. Under this programme of change, the WHO lists care transitions as one of three priority areas that need effective action in order to protect patients.
Transitions of care (such as admission to a healthcare facility, transfer between settings within a facility and at discharge, and also across different prescribers in community settings) can potentially lead to patient harm due to unintentional changes in medication or poor communication. A recent Cochrane review, for example, found that 55.9% of patients are at risk of having one or more medication discrepancies at transitions of care.(1) Such medication discrepancies can lead to secondary illnesses, hospital admissions and even deaths. Medicines reconciliation is a standardised process that involves obtaining a patient’s comprehensive current medication list and reviewing it in relation to medication requested or used in any new setting, in order to identify and resolve any discrepancies in medication frequency, route, dose, combination and therapeutic purpose.
“Medicines reconciliation represents a key service across all transitions of care and, when led by pharmacists, is effective in reducing medication-related harm to patients. With this service, pharmacists can apply their medicines expertise to minimise errors and optimise medicines use, resulting in positive impacts on patient, clinical and economic outcomes. Medicines reconciliation should be practised in every healthcare setting,” said FIP CEO Dr Catherine Duggan.
FIP’s toolkit on medicines reconciliation outlines the principles and important processes that pharmacists should follow when providing this professional service. It summarises the definitions, impact and procedures for the implementation of pharmacist-led medicines reconciliation in both community and hospital healthcare settings, and offers a set of tools to support practice.
“Medicines reconciliation could eliminate medication discrepancies at transitions of care if the required resources are made available. The FIP toolkit can also be used as a guide to inform practice models and influence decision-makers and pharmacy practitioners to set up or remodel medicines reconciliation processes,” Dr Duggan added.
FIP will be hosting a free webinar on medicines reconciliation, based on the toolkit, next month.
Reference
1. World Health Organization. Medication Safety in Transitions of Care. 2019. Available at www.who.int/patientsafety/medication-safety/TransitionOfCare.pdf?ua=1 (accessed on 17 February 2021).
Notes for editors
The World Health Organization’s third Global Patient Safety Challenge aims to reduce severe, avoidable medication-associated harm in all countries by 50% by 2022.
Link “Medicines reconciliation: A toolkit for pharmacists” is available here.
About FIP The International Pharmaceutical Federation (FIP) is the global federation of national associations of pharmacists and pharmaceutical scientists, and is in official relations with the World Health Organization. Through our 146 member organisations, we represent over four million practitioners and scientists around the world. Our vision is a world where everyone benefits from access to safe, effective, quality and affordable medicines and pharmaceutical care. www.fip.org
PRESS CONTACT
Lin-Nam Wang
Head of Corporate Communications & Advocacy
Email linnam@fip.org
Tel +31 70 302 1979